First human test of experimental drug BI 3034701 begins
NCT ID NCT06352437
First seen Nov 01, 2025
Summary
This study tested a new drug called BI 3034701 for the first time in humans. It involved 125 healthy men and people with overweight or obesity to see how safe the drug is and how it moves through the body. Participants received either the drug or a placebo as an injection under the skin. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.